Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Aimmune Therapeutics, Inc. (AIMT)
Sector: Healthcare; Industry: Biotechnology

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics; and clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study AR101 with adjunctive dupilumab in peanut-allergic patients in a Phase II trial. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-01-02 ADELMAN DANIEL C MD Chief Medical Officer Sell 20,000 $35.00 $700,038 Yes
2019-12-09 ADELMAN DANIEL C MD Chief Medical Officer Sell 20,000 $30.04 $600,716 Yes
2018-01-16 ADELMAN DANIEL C MD Chief Medical Officer Sell 36,717 $40.00 $1,468,680 Yes
2017-12-27 ADELMAN DANIEL C MD Chief Medical Officer Sell 3,283 $40.00 $131,320 Yes
2017-10-23 ADELMAN DANIEL C MD Chief Medical Officer Sell 10,000 $34.06 $340,610 Yes
2017-09-25 ADELMAN DANIEL C MD Chief Medical Officer Sell 10,000 $25.00 $250,000 Yes

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.